Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2004Concentration-time profile for perhexiline and hydroxyperhexiline in patients at steady stateJones, T.; Morris, R.; Horowitz, J.
2002Pharmacokinetic interaction between tacrolimus and diltiazem - dose-response relationship in kidney and liver transplant recipientsJones, T.; Morris, R.
2013Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsiesNoll, B.; Coller, J.; Somogyi, A.; Morris, R.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.
2007Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipientsWestley, I.; Taylor, P.; Salm, P.; Morris, R.
2001Population pharmacokinetics of perhexiline from very sparse, routine monitoring dataHussein, R.; Charles, B.; Morris, R.; Rasiah, R.
2001Population pharmacokinetics of lamotrigineChan, V.; Morris, R.; Ilet, K.; Tett, S.
2000Clinical study of lamotrigine and valproic acid in patients with epilepsy: Using a drug interaction to advantage?Morris, R.; Black, A.; Lam, E.; Westley, I.
2004Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexilineDavies, B.; Coller, J.; James, H.; Gillis, D.; Somogyi, A.; Horowitz, J.; Morris, R.; Sallustio, B.
2006Role of MRP2 in the hepatic disposition of mycophenolic acid and its glucuronide metabolites: Effect of cyclosporineWestley, I.; Brogan, L.; Morris, R.; Evans, A.; Sallustio, B.